Skip to main content
. 2020 Nov 11;23(12):1631–1638. doi: 10.1089/jpm.2020.0103

Table 2.

Patient Baseline and Follow-Up Self-Reported Symptom and Support Assessment

  Baseline (N = 11) Follow-up (N = 11) pa
Number of unique symptoms per patient, mean (SD) 3.7 (1.5) 2.6 (1.8) 0.034
Severity of symptom burden per patient, mean (SD)b 2.4 (1.1) 2.6 (1.3) 0.37
Any symptom, n (%) 11 (100) 10 (90.9)  
 Pain, n (%) 7 (63.6) 4 (36.4) 0.083
 Shortness of breath, n (%) 4 (36.4) 4 (36.4) 1.0
 Fatigue, n (%) 7 (63.6) 8 (72.7) 0.65
 Constipation or diarrhea, n (%) 5 (45.5) 2 (18.2) 0.083
 Nausea, n (%) 0 (0) 0 (0) 1.0
 Loneliness, n (%) 4 (36.4) 2 (18.2) 0.16
 Anxiety, n (%) 6 (54.5) 2 (18.2) 0.046
 Depression, n (%) 5 (45.5) 3 (27.3) 0.32
 Other symptom, n (%)c 3 (27.3) 4 (36.4) 0.56
Have support at home for symptoms, mean (SD)d 3.9 (0.5) 4.4 (0.2) 0.83
a

Wilcoxon signed rank tests comparing baseline and follow-up.

b

Measured for each symptom on an ordinal response scale (range 0–5; 5 signifying most severe) and averaged across all symptoms experienced by each patient.

c

Other symptoms include knee discomfort, swallowing problems, arthritis, poor walking, and losing balance.

d

Measured on an ordinal response scale (range 1–5; 5 indicating feeling supported all of the time).